Impact of adjuvant imatinib on bone and muscle density in patients with resected gastrointestinal stromal tumors

Adjuvant treatment with Imatinib is the standard of care for high-risk resected GISTs. Imatinib is known to have an impact on bone mineral density in patients affected by chronic myeloid leukemia, however this effect has never been investigated in GISTs. We retrospectively evaluated, on CT scans, th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fulgenzi, Claudia Angela Maria, Napolitano, Andrea, Faiella, Eliodoro, Messina, Laura, Castiello, Gennaro, Paternostro, Flavia, Silletta, Marianna, Pantano, Francesco, Tonini, Giuseppe, Santini, Daniele, Vincenzi, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931443/
https://www.ncbi.nlm.nih.gov/pubmed/35309238
http://dx.doi.org/10.1016/j.jbo.2022.100422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931443/
https://www.ncbi.nlm.nih.gov/pubmed/35309238
http://dx.doi.org/10.1016/j.jbo.2022.100422

Ejemplares similares